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Go´mez(6), and M. Bare´(4,7)
We propose a joint model to analyze the structure and intensity of the association between
longitudinal measurements of an ordinal marker and time to a relevant event. The longitudinal
process is deﬁned in terms of a proportional-odds cumulative logit model. Time-to-event is
modelled through a left-truncated proportional-hazards model which incorporates information of
the longitudinal marker as well as baseline covariates. Both longitudinal and survival processes are
connected by means of a common vector of random eﬀects.
General inferences are discussed under the Bayesian approach and include the posterior distribution
of the probabilities associated to each longitudinal category and the assessment of the impact of the
baseline covariates and the longitudinal marker on the hazard function. The ﬂexibility provided
by the joint model makes possible to dynamically estimate individual event-free probabilities and
predict future longitudinal marker values.
The model is applied to the assessment of breast cancer risk in women attending a population-based
screening program. The longitudinal ordinal marker is mammographic breast density measured with
the BI-RADS scale in biennial screening exams.
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1. Introduction
The current evidence on beneﬁts and harms supports the personalization of screening as a crucial step to improve
early detection of breast cancer [1,2]. A number of risk models were designed to measure the individual probability
of developing breast cancer [3–5]. In the context of individualized breast cancer screening, the utility of these risk
models has been questioned due to their low discrimination power [6]. The inclusion of a baseline measure of breast
density - a characteristic of the breast tissue - in the risk models improved the accuracy of the breast cancer risk
estimate [7–10].
Several studies have shown that high breast density is associated with increased breast cancer risk [7,11–14], with
risk estimates in the range four - to six - fold for women with very high breast density compared to women with
low breast density [11,12]. Other studies have examined whether changes in breast density over time are associated
to changes in breast cancer risk [15–21], and have suggested that monitoring changes in breast density could help
to identify women at greater risk of disease. In most of the cases, the statistical methods used did not account for
relevant characteristics of prospective studies like non-ignorable dropout mechanisms or internal time-dependent
covariates [22].
Joint modeling of longitudinal and time-to-event data is an increasingly productive area of statistical research
that assesses the association between longitudinal and survival processes. It enhances longitudinal modeling by
allowing for the inclusion of non-ignorable dropout mechanisms, and survival modeling by the inclusion of internal
time-dependent covariates [22]. Joint models were introduced during the 90s [23–25] and since then, have been
applied to a great variety of studies in epidemiological and biomedical areas. Shared-parameter models are a type
of joint models where the longitudinal and time-to-event processes are connected by means of a common set of
subject-speciﬁc random eﬀects. These models make possible to quantify both the population and individual eﬀects
of the underlying longitudinal outcome on the risk of an event, and obtain individualized time-dynamic predictions.
Recently, Rizopoulos proposed an overview of the theory and applications of joint modeling [26] and developed the
JM [27] and JMbayes [28] R packages for the frequentist and Bayesian shared-eﬀects’ approaches, respectively. Serrat
et al. illustrate the application of both statistical approaches to joint modeling longitudinal measures of prostate
speciﬁc antigen (PSA) and prostate cancer detection in men participating in a screening trial [29].
When longitudinal outcomes are ordinal, joint models become more complex. Diﬀerent approaches, that use
constraints in the probabilities of the categorical outcomes or the discretization of a continuous latent variable,
have been proposed [30–33]. The non-linear and longitudinal nature of the data produce a complex likelihood
function, diﬃcult to maximize under the frequentist paradigm. This could be a reason why the standard software
for joint models does not include longitudinal ordinal variables yet. Some relevant works on the subject use the
frequentist [34–36] and Bayesian [33, 37, 38] approaches, respectively.
The objective of this paper is to propose a Bayesian joint model for assessing the structure and intensity of
the association between longitudinal measures of an ordinal marker and a time-to-event outcome. In particular,
we use a proportional-odds cumulative logit model [30] for the ordinal measurements and a proportional hazard
model with left-truncation for the time to an event of interest. We have applied the model to analyze the risk of
breast cancer in women attending a population-based screening program with regard to repeated measurements of
mammographic breast density.
Section 2 presents a description of the motivating dataset. Section 3 formulates the joint model and discusses
general inferences for 1) dynamic probabilities associated to the diﬀerent ordinal categories, 2) the impact of baseline
covariates and the longitudinal marker on the hazard function, 3) dynamic estimation of survival probabilities, and
4) prediction of future longitudinal outcomes. Section 4 applies the model developed in Section 3 to study age at
diagnosis of breast cancer in women who participate in a population-based screening program. Finally, Section 5
contains a discussion and some conclusions.
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2. Motivating data
2.1. Study design and study population
This is an observational prospective study including 13 760 women that participated for the ﬁrst time in the breast
cancer early-detection program in the Valle`s Occidental Est (BCEDP-VOE) area in Catalonia (Spain), between
October 1995 and June 1998. The BCEDP-VOE invites women aged 50-69 years for biennial mammographic exams.
At study entry, the participants were 50-70 years old and did not have a personal history of breast cancer. They
were followed for vital status or possible diagnosis of breast cancer until December 2013 [39–41].
Of the initial 13 760 women, we excluded seven without follow-up data, as well as 38 women who were diagnosed
with breast cancer and nine who died within six months of baseline. Twenty-one women were also excluded for not
having breast density measurements within the 50-70 age interval. We analyzed invasive breast cancer and ductal
carcinoma in situ (DCIS) diagnosed during follow-up. The ﬁnal sample included 13 685 women, with 431 diagnosed
with breast cancer.
2.2. Variables and data description
At the ﬁrst mammographic exam, the study participants answered a questionnaire that included information
on family history of breast cancer, prior breast procedures, age at menarche, age at ﬁrst birth, and menopausal
status. Family history refers to absence/presence of ﬁrst-degree relatives with breast cancer. Prior breast procedures
included breast biopsy, ﬁne needle aspiration, cyst aspiration, breast reconstruction, lumpectomy and surgical
treatment.
Breast density is a characteristic of the breast tissue that is reﬂected in mammograms. Breasts are considered
dense if the connective and epithelial tissues predominate over the fatty tissue. At all mammographic exams
breast density was rated and recorded according to the BI-RADS system [40] which categorizes breast density
in four groups: a, almost entirely fatty (low density); b, scattered ﬁbroglandular densities (medium density); c,
heterogeneously dense (high density); and d, extremely dense (very high density). This longitudinal breast density
data is a remarkable and unique characteristic of the BCEDP-VOE among the breast cancer screening programs in
Spain. Breast density measures within 6 months before breast cancer diagnosis could be aﬀected by the presence of
preclinical breast cancer, therefore they were excluded. The mammographic exams performed before age 50 or after
age 70 were excluded in order to avoid sample biases. A total of 81 621 measures of breast density were included in
the longitudinal analysis, with median [range] 4 [1 to 9] and 6 [1 to 15] measures for women with or without breast
cancer diagnosis, respectively.
We considered that the time origin for the event of interest (diagnosis of breast cancer) was age 50 years, the lower
limit of the screening age interval. We deﬁned the time-to-event as the time elapsed from the origin to diagnosis
of breast cancer. For women without a breast cancer diagnosis at the study end, the censoring time was obtained
as the minimum of time to death and time to the last screening exam plus 2.5 years that correspond to the active
follow-up for cancer identiﬁcation. It is important to remark that women who entered the program over 50 years
had delayed entry times that may induce length biased sampling or left truncation.
Table 1 around here
Among 13 685 women aged 50 years and older, 431 developed breast cancer –336 invasive cancers and 95 DCIS–,
and 513 died within 2.5 years of the last mammogram. Median follow-up was 12.7 years for women without breast
cancer and 8.2 years for women with breast cancer. Table 1 shows the baseline characteristics of women and the
breast density measurements at ﬁrst and last examination according to their breast cancer diagnosis status at the
end of follow-up. High breast density categories were more prevalent among women with breast cancer, in both
the ﬁrst and the last mammogram. Furthermore, between the ﬁrst and last exams, the prevalence of low density
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categories increased, as described in the literature.
Figure 1 around here
To illustrate the longitudinal breast density measurements, we randomly selected eight women without and eight
women with cancer (Figure 1). A high variability of the breast density trajectories can be observed: some women
experience an increase of breast density, while others remain stable, ﬂuctuate, or experience a decrease. The plots
show the biennial periodicity of the screening exams, as well as the unbalanced number of measures between women,
due to diﬀerent reasons. Not all women entered the study at the same age, not all the scheduled screening exams
were taken, or not always breast density was rated.
3. The joint model
We propose a model with two submodels: (1) a proportional-odds cumulative logit model for the longitudinal
ordinal measurements based on the idea of a continuous latent variable [30,33], and (2) a left-truncated proportional
hazard model for the time-to-event, which incorporates information from the longitudinal process. Both processes
are connected through a shared vector of random eﬀects, which, in the presence of covariates and parameters,
endows them with conditional independence [26].
Let {D1, D2, . . . , DK} denote the set of ordinal categories and yij the longitudinal category of individual i,
i = 1, . . . , n, at time tij , j = 1, . . . , ni. We assumed an underlying continuous latent variable y
∗
ij that determines the
ordinal category of individual i at time tij . This latent variable has no interest per se but it is useful for motivating
and interpreting the cumulative logit model. The relationship between yij and y
∗
ij is stated as
yij = Dk ⇔ y∗ij ∈ (γk−1, γk], k = 1, . . . ,K,
where −∞ = γ0 < γ1 < . . . < γK−1 < γK = ∞ are unknown cut-points. We assumed a logistic distribution for
y∗ij , Lo(mij , s = 1), with location parameter mij (mean) and a common scale parameter s = 1 for achieving
identiﬁability. The choice of that distribution implies a logit link for the cumulative probabilities
qijk = P (yij > Dk) = P (y
∗
ij > γk) =
1
1 + exp(γk −mij) , (1)
and therefore,
logit qijk = log
(
qijk
1− qijk
)
= mij − γk.
Despite the fact that s = 1 in the logistic distribution of the latent variable, the model is overparameterized (any
set of k probabilities can be obtained increasing the cut-points in the same quantity). To obtain an identiﬁable
model, we arbitrarily introduced a reference point on the latent scale, in particular γK/2 = 0 if K is even and
γ(K−1)/2 = 0 or γ(K+1)/2 = 0 if K is odd.
We considered a mixed-eﬀects model to describe the subject-speciﬁc time trajectories of the latent variable
y∗ij = mij + ij = x
(l)′
ij β + z
′
ijbi + ij , (2)
where x
(l)
ij is a P dimensional vector of covariates relevant to the longitudinal process, as indicated by superscript
(l), for individual i at time tij with regression coeﬃcient (populational) β; zij the vector of explanatory variables
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attached to the vector of random eﬀects bi for the i-th individual at time tij ; and ij an error term for the i-th
individual at time tij , modeled in terms of a logistic distribution, Lo(0, 1). The random eﬀects b = (b1, . . . , bn)
T
are conditionally i.i.d. (given the hyperparameter vector φ) with (bi | φ) ∼ f(bi | φ).
Let Ti, i = 1, . . . , n, be the observed event time for the i-th subject, obtained as the minimum between the true
failure time, T ∗i , and the right-censoring time, Ci, Ti = min(T
∗
i , Ci). The event indicator δi = I(T
∗
i ≤ Ci) takes the
value 1 if the observed time corresponds to a true event time, and 0 otherwise. In addition, event times corresponding
to individuals who enter the study at delayed entry times introduce left-truncation, thus deﬁning the subsequent
hazard function as zero in the period before the entrance of the individual to the system [43]. In particular, we
consider the hazard function of T ∗i in terms of a left-truncated relative risk regression model
hi(t) = h0(t) exp{x(s)′i η + αmit}, t > ai, (3)
and zero otherwise, where h0(t) is the baseline risk function; x
(s)
i represents the vector of baseline covariates relevant
to the survival process, as indicated by superscript (s), with associated coeﬃcients η; α assesses the eﬀect of the
longitudinal marker of subject i on the event of interest in terms of the latent variable mean; ai is the delayed
entry time of individual i. It is important to comment that left-truncated data will add computational complexity
to the modeling because the likelihood function corresponding to this type of data will incorporate conditional
probabilities which contain the information that the individual is alive in the period between their theoretical
entrance at time zero and their real entrance to the system.
To complete the Bayesian model, it is necessary to elicit a prior distribution, π(θ) for all the unknown
parameters and hyperparameters of the joint model θ = (β,η, α,γ,φ)T . Our joint model contains parameters
and hyperparameters, θ, and random eﬀects b. From a Bayesian perspective, π(θ, b | D), where D represents all the
data collected from the longitudinal and the survival processes, is the joint posterior distribution of the parameters,
hyperparameters, and random eﬀects, which can be obtained by the hierarchical modeling
π(θ, b | D) = L(θ, b | D) f(b | φ)π(θ). (4)
L(θ, b | D) is the likelihood function of θ and b for data D, f(b | φ) the distribution of the random eﬀects b given φ
introduced before, and π(θ) the prior distribution for θ. Markov Chain Monte Carlo (MCMC) simulation methods
allow to obtain an approximated random sample from the posterior π(θ, b | D), which is the key element and the
starting point of all relevant inferences.
Finally, it is worth noting that when inference is carried out under the Bayesian formulation, the shared joint
model will induce conditional independence between the longitudinal and the survival processes given not only the
random eﬀects and covariates but also given all the parameters and hyperparameters in the model, as a result of
its stochastic role in Bayesian inference.
3.1. Dynamic probabilities associated to ordinal categories
From expression (1), the probability distribution of the ordinal marker yit for individual i at time t can be computed
in terms of the logistic distribution of their latent variable y∗it as
P (yit = Dk | x(l)it , θ, bi) = P (y∗it ∈ (γk−1, γk) | x(l)it , θ, bi), k = 1, 2, . . . ,K. (5)
These probabilities depend on θ, bi, and the relevant covariates associated to that individual. Consequently, we
could use the posterior marginal distribution π(θ, bi | D) for computing the posterior distribution, π(P (yit = Dk |
x
(l)
it , θ, bi) | D), of all the relevant dynamic probabilities for each individual in the study.
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A complementary and overall perspective of the temporal evolution of the diﬀerent categories of the ordinal
marker is based on the marginal distribution
P (yit = Dk | x(l)it , θ) =
∫
P (yit = Dk | x(l)it , θ, bi) f(bi | φ) dbi, (6)
which is computed by integrating out the random eﬀects of the conditional distribution (5). This distribution only
depends on θ. It can be interpreted as the time-speciﬁc population distribution of the longitudinal marker for a
generic individual of the population with covariate values x
(l)
it . Consequently, we can use our current information
about θ expressed through π(θ | D) and compute the posterior distribution π(P (yit = Dk | x(l)it , θ) | D) for each
ordinal category Dk. This posterior distribution provides point estimates of these relevant probabilities such as
posterior expectations
E(P (yit = Dk | x(l)it , θ) | D) =
∫
P (yit = Dk | x(l)it , θ)π(θ | D) dθ = P (yit = Dk | x(l)it ,D), (7)
as well as credible intervals for measuring the uncertainty of the estimation.
Our model also allows to explore the estimated relationship between the ordinal and latent variables. We could
address the posterior distribution of the latent variable y∗it for each time with regard to each individual in the study
or a generic one. The logistic distribution, Lo(mit, s = 1), for the latent variable y
∗
it is a conditional distribution with
an unknown mean that depends on θ and bi. The subsequent marginal distribution f(y
∗
it | x(l)it , θ) can be obtained
as in (6) integrating out the random eﬀects, and can be interpreted as a time-speciﬁc population distribution of
the latent variable for a generic individual. Again, this marginal distribution is also a conditional distribution that
depends on the population parameters θ and the posterior distribution of the latent variable can be estimated as
f(y∗it | x(l)it ,D) =
∫
f(y∗it | x(l)it , θ)π(θ | D) dθ. (8)
3.2. Impact of the covariates on the risk of the event
The hazard ratio (HR) of an individual with covariates x having the event as compared to an individual with
covariates x∗ is exp{∑Pp=1 ηp(xp − x∗p)}, where P is the number of covariates. This hazard ratio only depends on
η, the vector of regression coeﬃcients in 3. Consequently, its posterior distribution,
π(exp{∑Pp=1 ηp(xp − x∗p)} | D), (9)
computed from the approximate MCMC sample from the posterior marginal π(η | D), provides all the relevant
information about that HR.
The association parameter α allows to assess the relationship of the mean of the latent density with the hazard
function, but does not provide a direct link with the ordinal longitudinal variable. To facilitate an interpretation
of the association parameter in terms of the ordinal measurements, we propose the following ad-hoc procedure:
1. Compute the posterior mean, E(γk | D), of the cut-points γk and construct the posterior intervals (E(γ(k−1) |
D), E(γk | D)), k = 1, . . . ,K.
2. Deﬁne for a given time t a representative value m˜kt, k = 1, . . . ,K of the mean of each ordinal category in the
latent scale as follows
(a) Compute the median of the posterior distribution (8) in each interval (E(γ(k−1) | D), E(γk | D)), and
consider them, y˜∗kt, as the representative value of the latent variable y
∗ in each ordinal category.
(b) For each y˜∗kt, generate a value m˜kt of the latent mean according to the general formulation (2) y
∗ = m+ ,
or equivalently m = y∗ − , where  is a random error with logistic distribution Lo(0, 1).
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3. Approximate the conditional HR, given α, of an individual in the ordinal category k having the event versus
an individual in category k′ at time t as eα(m˜kt−m˜k′t).
4. Compute the posterior distribution of the approximate HR in step 3 from the marginal posterior distribution
of α as
∫
eα(m˜kt−m˜k′t) π(α | D) dα.
3.3. Prediction
Bayesian reasoning approaches the estimation of the conditional survival probability of an individual i with
a given history provided by their baseline covariates and longitudinal follow-up Yini (which guarantees that
their survival time is greater than the time, tini , of their last longitudinal measurement) through the posterior
distribution π(P (Ti ≥ t | Ti > tini ,Yini ,xi, θ, bi) | D), t > tini . This posterior contains all relevant information
about the location and variability of this conditional survival probability over time. In particular, its posterior
mean can be more easily computed as
P (Ti ≥ t | Ti > tini ,Yini ,xi,D) =
∫
P (Ti ≥ t | Ti > tini ,Yini ,xi, θ, bi)π(θ, bi | D,Yini , Ti > tini) d(θ, bi)
=
∫
P (Ti ≥ t | Ti > tini ,xi, θ, bi)π(θ, bi | D,Yini , Ti > tini) d(θ, bi), t > tini ,
(10)
where the conditional probability P (Ti ≥ t | Ti > tini ,Yini ,xi, θ, bi) does not depend on the particular longitudinal
trajectory, Yini , as a result of the induced independence of the shared eﬀects joint model, and π(θ, bi | D,Yini , Ti >
tini) is the marginal posterior distribution of the common parameters’ and random eﬀects’ vector for individual i,
given Yini and Ti > tini .
We could also approach prediction of a future longitudinal measurement of an individual in the study [44]. The
posterior predictive distribution of a new longitudinal measurement yi,ni+1 at the time ti,ni+1 of a future scheduled
appointment for individual i with covariates xi and longitudinal ordinal history Yini is given by
P (yi,ni+1 = Dk |Ti > ti,ni+1,Yini ,xi,D) = P (y∗i,ni+1 ∈ (γk−1, γk] | Ti > ti,ni+1,Yini ,xi,D)
=
∫
P (y∗i,ni+1 ∈ (γk−1, γk] | Ti > ti,ni+1,Yini ,xi, θ, bi) π(θ, bi | D,Yini , Ti > ti,ni+1) d(θ, bi)
=
∫
P (y∗i,ni+1 ∈ (γk−1, γk] | xi, θ, bi)π(θ, bi | D,Yini , Ti > ti,ni+1) d(θ, bi) (11)
where
P (y∗i,ni+1 ∈ (γk−1, γk] | xi, θ, bi) =
eγk−mi,ni+1 − eγk−1−mi,ni+1
(1 + eγk−mi,ni+1)(1 + eγk−1−mi,ni+1)
is obtained from (1), with mi,ni+1 = (β0 + bi0) + (β1 + bi1)ti,ni+1. The conditional probability P (y
∗
i,ni+1
∈
(γk−1, γk] | Ti > ti,ni+1,Yi,xi, θ, bi) is independent on the survival history, Ti > ti,ni+1, as a consequence of the
shared random eﬀects joint model. Note also that the diﬀerent longitudinal measurements of the same individual
are independent given (θ, bi).
The previous two posteriors both apply to individuals in the study and to individuals of the population that
could be involved in the study in the future. In this framework, some discussion about the posterior distribution
π(θ, b | D,Yini , Ti > tini) becomes necessary. If the interest concentrates on a speciﬁc individual in the study, such
as individual i, for whom we want to estimate the conditional probability (10) or the predictive distribution (11)
from the current data D, the information provided by Yi and Ti > tini is already included in D. Consequently,
π(θ, b | D,Yini , Ti > tini) = π(θ, b | D). If the interest focuses on sequentially estimate (10) or/and predict (11) as
a result of their follow-up, we would need to sequentially update the current posterior distribution π(θ, b | D) with
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all that new relevant follow-up information, in particular new longitudinal measurements and the updated survival
time.
Dynamic posterior estimation and prediction for individuals of the population who have not participated in the
study are also possible. Let consider now a new subject i′ who initially has not participated in the inferential process
and enters the study at time ai′ with given values xi′ of the baseline covariates. The posterior distribution of their
unconditional survival probability is π(P (Ti′ ≥ t | Ti′ > ai′ ,xi′ , θ, bi′) | D) with posterior mean
P (Ti′ ≥ t | Ti′ > ai′ ,xi′ ,D) =
∫
P (Ti′ ≥ t | Ti′ > ai′ ,xi′ , θ, bi′)π(θ, bi′ | D, Ti′ > ai′) d(θ, bi′)
=
∫
P (Ti′ ≥ t | xi′ , θ, bi′)
P (Ti′ > ai′ | xi′ , θ, bi′) π(θ, bi
′ | D, Ti′ > ai′) d(θ, bi′), (12)
Prediction of their ﬁrst longitudinal measurement planned at a ﬁxed time ti′1 > ai′ is
P (yi′,1 = Dk |Ti′ > ai′ ,xi′ ,D) = P (y∗i′,1 ∈ (γk−1, γk] | Ti′ > ai′ ,xi′ ,D)
=
∫
P (y∗i′,1 ∈ (γk−1, γk] | Ti′ > ai′ ,xi′ , θ, bi′) π(θ, bi′ | D, Ti′ > ai′) d(θ, bi′)
=
∫
P (y∗i′,1 ∈ (γk−1, γk] | xi′ , θ, bi′) π(θ, bi′ | D, Ti′ > ai′) d(θ, bi′) (13)
If as a consequence of the follow-up of this individual we would like to compute posterior probabilities of the type
(10) and/or (11), the subsequent marginal posterior distribution will come from the joint posterior distribution
π(θ, b, bi′ | D,Yi′ni′ , Ti′ > ti′ni′ ), which includes the common parameters and hyperparameters θ, the vector of
random eﬀects b associated to the original individuals in the study and those of that new individual considered, bi′ .
From a Bayesian point of view, the incorporation of sequential information from an individual who is already
involved in the study or from the follow-up of a future subject implies the need of sequentially update the
posterior distribution π(θ, b | D). In the case of studies based on samples with large sample size, we would expect
a minimal change in the estimation of the common parameters but possibly not in the subject speciﬁc random
eﬀects. The process of updating a posterior distribution for which we only have an approximate random sample
and not an analytical distribution is conceptually easy but not so in practice. The main tools to carry out this
computational process are based on Sequential MCMC methods [45,46] and although are beyond the scope of this
paper are a current aim of our research team. Rizopoulos [47] proposes, as an approximation of the subsequent
posterior distribution, updating the speciﬁc random eﬀects associated with individuals. In particular, the author uses
empirical Bayesian estimation for the random eﬀects and an asymptotic normal distribution, based on maximum
likelihood estimation, for the common population parameters. Taylor et al. [48] also separately update the vector
of random eﬀects by using a quick MCMC based on a prior distribution for the population parameters coming from
the marginal posterior π(θ | D).
4. Joining longitudinal breast density and age at breast cancer detection
Let {D1, D2, D3, D4} denote the set of BI-RADS breast density categories {a, b, c, d}, which represent low, medium,
high, and very high density, respectively, yij the breast density category of woman i, i = 1, . . . , n, at time tij (age
50 + tij), j = 1, . . . , ni and y
∗
ij her subsequent underlying continuous latent value.
Following (3) the connection between both processes is
yij = Dk ⇔ y∗ij ∈ (γk−1, γk], k = 1, 2, 3, 4,
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where −∞ = γ0 < γ1 < γ2 < γ3 < γ4 = ∞ are unknown cut-points, with γ2 = 0, and Lo(mij , s = 1) represents the
corresponding logistic distribution for y∗ij .
Considering the evidence of a decreasing trend of breast density with age and a linear trajectory for the
longitudinal latent breast density of woman i
(y∗i (t) | mit) = mit + it = (β0 + bi0) + (β1 + bi1)t+ it, (14)
where (β0, β1)
T and (bi0, bi1)
T are the ﬁxed (population) and random eﬀects (individual) for the intercept and
the slope term, respectively, and it the error term. Random eﬀects (b0, b1)
T , where b0 = (b01, . . . , b0n)
T and
b1 = (b11, . . . , b1n)
T , are assumed conditionally i.i.d. with (bi0 | σ0) ∼ N(0, σ0) and (bi1 | σ1) ∼ N(0, σ1).
The hazard function of age at breast cancer diagnosis is deﬁned in terms of the left truncated relative risk
regression model
hi(t | xi, θis, t∗i > ai) = h0(t | λ, η0) exp{η1Famhisti + η2Brstproci + αmi(t)}, t > ai, (15)
where h0(t | λ, η0) = λtλ−1 eη0 is the baseline risk function of a Weibull distribution, We(λ, eη0); family history of
breast cancer (Famhist) and prior breast procedures (Brstproc) are dychotomous baseline covariates with associated
coeﬃcients η1 and η2 respectively; α assesses the eﬀect of the individual trajectory of breast density on breast
cancer risk in terms of the latent breast density mean; and ai is the age over 50 at which woman i enters the
screening program thus providing the left truncated time [43].
We assumed prior independence among all the parameters and hyperparameters as a default speciﬁcation and,
with the aim of giving all inferential prominence to the data, we elicited wide proper prior distributions. For
the parameters in the longitudinal submodel we followed Lunn et al. [30] except for the standard deviations. In
particular, we selected N(0, 100) for the β’s regression coeﬃcients. The ordinal constraint for the cutpoints of the
latent scale, −∞ < γ1 < γ2 = 0 < γ3 < γ4 = ∞, was expressed by truncating the subsequent prior distributions in
the appropriate parametric subspace
γ1 ∼ N (−log(3), σγ1 = 100)I(−∞, γ2 = 0),
γ3 ∼ N (log(3), σγ3 = 100)I(γ2 = 0,∞),
where I(−) is the indicator function. Prior means for γ1 and γ3 respectively correspond to the ﬁrst and third
quartiles of a logistic distribution Lo(0, 1) in order to provide the same prior probability to each response category.
For the standard deviations σ0 and σ1 we choose a uniform distribution, Un(0, 10). In the case of the survival
submodel we selected N(0, 100) for the η’s regression coeﬃcients as well as for the association coeﬃcient α, and
a gamma distribution Ga(1, 1) for the parameter λ of the baseline hazard function because it mimics a constant
baseline hazard function [49].
4.1. Posterior distribution
The posterior distribution π(θ, b | D) was computed in terms of the hierarchical modelling (4) and approximated
using MCMC simulation methods through the JAGS software [50]. In particular, we run three MCMC chains with
100 000 iterations, 10 000 of which were used for the burn-in period. The chains were thinned by only storing every
270th iteration in order to reduce autocorrelation in the saved sample. Trace plots of the simulated values of the
three chains appear overlapping one another indicating stabilization. Convergence of the chains to the posterior
distribution was assessed through the potential scale reduction factor, Rˆ , and the eﬀective number of independent
simulation draws, neff , [51] and [52], respectively. Rˆ compares the within-chain variance to the estimated variance
of the posterior distribution in such a way that Rˆ values near 1 indicate that the simulated process has reached the
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posterior distribution. neff deals with the level of autocorrelation of the chains simulated values, so that neff > 100
indicates that suﬃcient MCMC samples have been obtained.
Table 2 summarizes the approximate MCMC random sample from the marginal posterior distribution π(θ | D)
through the mean, median, standard deviation, 2.5% and 97.5% percentiles. The last column of Table 2 contains
the probability that the corresponding parameter is positive: a 0.5 probability would indicate that a positive value
of the parameter is equally likely that a negative one, hence indicating little relevance of the corresponding variable
(given the remaining covariates). This is not the case for the parameters of our model with probabilities that show
a clear preference for being above or under zero.
Table 2 around here
The marginal posterior distribution associated to the population intercept β0 and slope β1 of the mean of the
latent breast density clearly states that both are negative, P (β0 < 0 | D) = P (β1 < 0 | D) = 1, indicating decreasing
values over time of the true latent breast density, and therefore a higher probability of being in the lower breast
density categories with age. The variability associated with the random intercept is important, E(σ0 | D) = 2.6067,
as a sign of high population heterogeneity with regard to initial breast density. In contrast, there is small variability
in the subject-speciﬁc slopes, E(σ1 | D) = 0.0053, which denotes that subject-speciﬁc trajectories of the true latent
breast density do not diﬀer much from the population trend. The estimation of the cut-points γ1 and γ3 is very
stable and accurate. The posterior means of the coeﬃcients associated to the baseline covariates, family history of
breast cancer and prior breast procedures, 0.6227 and 0.4535, respectively, indicate an increase of risk of breast cancer
detection when women have one or both of these risk factors. These values are consistent with the ones reported
in the literature. The strength of the association between the breast density and age at breast cancer diagnosis is
assessed through their posterior expectation E(α | D)=0.149 and 95% credible interval (0.1089, 0.1887). In addition,
the posterior probability 1 for that coeﬃcient being positive provides strong support on the connection between
breast density and breast cancer risk.
4.2. Probabilities associated to breast density BI-RADS categories
Figure 2 (top) shows the posterior mean and 95% credible interval of the posterior distribution
π(P (yit = Dk | θ) | D) associated to each BI-RADS category for a generic woman in the study. Probabilities
associated to category BI-RADS b are always higher than 0.5, and grow slightly with age. Probabilities for
categories a, c, and d are initially very similar, but categories c and d decrease with age following a similar pattern
while category a increases (see Table ?? in Appendix). The information provided by credible intervals is very
valuable thus indicating high precision in the estimated means.
Figure 2 around here
Figure 2 (bottom) shows a violin plot (a combination of a kernel density plot and a boxplot) of the posterior
marginal distribution of the latent breast density at ages 50, 55, 60, 65 and 70. The four categories of the ordinal
breast density are marked with regard to the posterior mean of the cut points γ1 and γ3, and γ2 = 0. The visual
comparison between real and latent results is very interesting. We clearly appreciate that the posterior marginal
distribution of the latent breast density tends towards lower values with age. In addition, the bottom tail of the
distributions increase with age in detriment of the top tail thus indicating the general decreasing of breast density
with age.
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4.3. Assessment of the impact of the study variables on breast cancer risk
Relevant HRs arise from the combination of baseline covariate categories. Figure 3 shows the posterior distribution
of the HRs of a breast cancer diagnosis for family history of breast cancer, prior breast procedures, and both risk
factors, with posterior means 1.864, 1.574, and 2.934, respectively. The marginal eﬀects of each covariate are
relevant, with posterior probabilities 0.998 and 1.000 associated to HR values greater than 1 for family history of
breast cancer and prior breast procedures, respectively.
Figure 3 around here
Following the ad-hoc procedure presented in subsection 3.2, Figure 4 shows the posterior mean and 95% credible
intervals with regard to age of the approximate HR of a breast cancer diagnosis for women with breast densities b,
c, and d compared to women with the same covariate values and breast density a. Changes in breast density from
category a towards more dense categories have a strong eﬀect on breast cancer risk. We observe posterior means of
the HR around 4 for category d versus a, and HRs greater than 1 (around 1.7 and 2.6) when comparing categories
b and c versus a, respectively. A gently wavy behaviour for the posterior distributions and credible intervals of the
HRs with respect to age can be appreciated, as a consequence of the simulation of the logistic error in the procedure.
Figure 4 around here
4.4. Prediction
Figure 5 shows the posterior mean (10) and 95% credible band for four of the women without cancer in Figure
1, at the end of follow-up. As expected, breast cancer-free probabilities are very high and decrease with age. It is
worth noting the narrowness of the bands corresponding to women with a higher number of density measurements,
possibly due to the precision of the random eﬀects estimates. Women with high breast density values seem to
have lower breast cancer-free survival probabilities. However, we must also consider the baseline risk factors. Thus,
disease-free survival is higher for woman 942, who has a stable very high breast density, than for woman 9 672, who
experiences a decrease in density. This result can be attributed to presence of prior breast procedures in woman
9 672 and absence of them in woman 942. Both women do not have family history of breast cancer.
Figure 5 around here
Figure 6 around here
Figure 6 shows the posterior predictive distribution of the ordinal breast density categories for the women in
Figure 5. We appreciate a great variability among the predicted BI-RADS trajectories, and for most of the selected
women, category b has the highest probabilities over age. But, for woman 5318 category a is always the most
prevalent with an increasing trend over age, followed by categories b, c and d. These results are in line with the
observed breast density trajectory for this woman: three breast density measurements with values b, a and a at
late ages 65, 67 and 69, respectively. In contrast, for woman 942 category d is always the most prevalent with a
decreasing trend over age. These results are also consistent with the observed breast density trajectory for this
woman, stable with very high breast density at relatively late ages 61, 63, 65, 67, and 69.
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5. Discussion
We propose a Bayesian joint model that combines the information provided by a longitudinal ordinal process and a
left-truncated time-to-event outcome. The joint density of both processes is approached through a shared-parameter
model which generates a structure of association and conditional independence between both outcomes by means
of a vector of common random eﬀects.
We chose a latent variable formulation for the longitudinal process which translated the ordinal scale to the
framework of linear mixed models, with a logistic distribution for the measurement error. The latent variable
approach facilitates the computational implementation of the model but introduces complexity in the interpretation
of results. We assume a logistic distribution for the latent variable which implies the logistic link for cumulative
probabilities. Other models might be also appropriate. The most usual alternatives are the normal and the extreme
value distributions which result in the probit and complementary log-log regression links, respectively. It is widely
accepted that probit and the logit links produce similar results. This also occurs in our study (results not shown),
where we have implemented the probit link to assess the robustness of the model. This is not the case for the
extreme value distribution which, unlike the logistic and normal ones, is not symmetrical.
We consider that the cut-points that relate the ordinal and latent variables are common for all individuals and
time. This assumption may produce some stiﬀness in the longitudinal model. Thus, individual or time speciﬁc
cut-points might endow of more ﬂexibility to the longitudinal latent variable at the expense of a more complex
model. Dealing with more than four categories in the ordinal variable is not straightforward. One of the reasons
for this is that one or both of the endpoints of the truncated intervals in which the marginal prior distribution of
each unknown cut-point is deﬁned can be also unknown [53]. The estimation of these models involve important
computational issues in the MCMC sampling which have provided many discussion and proposals, such as hybrid
Metropolis-Hasting algorithms to sample from the subsequent posterior distribution [54, 55].
Robustness is a major statistical concern in Hierarchical Bayesian models because it can be aﬀected by an
inappropriate choice of hyperprior distributions for hyperparameters. We have tested the sensitivity of the model
using other prior speciﬁcations for the hyperprior distribution of the random eﬀects scale parameter. In particular,
we have considered a wide uniform distribution, Un(0, 100), as an alternative to the elicited Un(0,10) in the paper
and inverse-gamma hyperdistributions, IGa(0.01, 0.01) and IGa(0.001, 0.001), due to their common use in Bayesian
applications. All of them provided almost identical results (not shown in the paper), possibly because of the large
sample size.
Our proposal could be applied to a variety of real problems devoted to analyze time-to-event outcomes with
temporal ordinal endogeneous covariates.We explore the role of death prior to breast cancer diagnosis as a competing
risk. The cumulative incidences estimated with the Kaplan-Meier method or the competing risks with cause-speciﬁc
hazards approach are very similar, even at older ages (See Figure A1 in the Supplementary ﬁle). Therefore, even
though the censoring due to the competing risk “death” was informative, it would hardly aﬀect our estimates. Event
times have been modeled in terms of relative risk models with left-truncation as a corrective mechanism for the
delayed entry bias. Left truncation is common in observational studies of risk factors, where not all the participants
enter the study at time zero. We select the Weibull distribution as baseline risk function because it is a traditional
model for survival data with a great ﬂexibility in representing diﬀerent types of risk. The exploration of more
sophisticated baseline risk functions, which include multimodality and heavy tailed distributions, in the area of
Bayesian joint modeling is a relevant subject with strong connections with the speciﬁcation of prior distributions.
See [56] for a detailed explanation of piecewise constant hazard models and Gamma processes. In addition, the
latent linear mixed model is a ﬂexible model that can accommodate heterogeneous trajectories, from linear to
complex functions. This is the case of linear models expressed in terms of spline bases to accommodate non-linear
proﬁles [57].
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We have used our joint model for analyzing the relationship between mammographic breast density and breast
cancer risk in women attending a public screening program. A linear subject-speciﬁc trajectory of the latent variable
is included in a relative risks survival model together with two of the most known breast cancer risk factors, family
history of breast cancer and previous breast procedures. Our joint model for breast cancer and breast density is a good
starting point that provides results consistent with the literature [16, 18, 19, 21]. They are the basis for a rationale
for extending the model and assessing its adequacy and accuracy. Evaluating the ability of breast density to predict
time to breast cancer diagnosis, under our joint model, by means of calibration and discrimination measures [58] is
a major concern of our research. The discriminative power of our model should oﬀset its complexity. Discrimination
measures based on Receiver Operating Characteristic (ROC) curves are commonly used for assessing predictive
accuracy. We are currently exploring a general latent variable approach that could be appropriate.
In contrast to studies published to date, our study is the ﬁrst to have used the complete longitudinal history of
breast density for assessing breast cancer risk over time, at population and individual level. Potential beneﬁts of the
proposed joint model include obtaining individual predictions of time-free of breast cancer at age u > t, given the
observed responses up to age t, and also individual longitudinal predictions of future breast density values. Thus, a
joint model similar to that shown here could be used for surveillance of breast cancer risk over time, for scheduling
screening exams based on individual dynamic predictions, and also in discussing prevention strategies for those at
high risk [16].
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6. Tables and Figures
Table 1.Baseline risk factors according to breast cancer diagnosis status at the end of follow-up.
No breast cancer Breast cancer
N=13 254 N=431
Family history of breast cancer
No 12 539 (94.8%) 388 (90.2%)
Yes 686 (5.2%) 42 (9.8%)
Prior breast procedures
No 12 318 (92.9%) 374 (86.8%)
Yes 936 (7.1%) 57 (13.2%)
Breast density at ﬁrst examination
(baseline breast density)
a: Almost entirely fatty 2959 (23.4%) 56 (13.9%)
b: Scattered ﬁbroglandular densities 5353 (42.3%) 138 (34.2%)
c: Heterogeneously dense 2301 (18.2%) 103 (25.6%)
d: Extremely dense 2037 (16.1%) 106 (26.3%)
Breast density at last examinationa
(women with at least two examinations)
a: Almost entirely fatty 2284 (18.1%) 35 (9.4%)
b: Scattered ﬁbroglandular densities 7957 (63.0%) 201 (54.0%)
c: Heterogeneously dense 1475 (11.7%) 71 (19.1%)
d: Extremely dense 919 (7.3%) 65 (17.5%)
a If breast cancer was diagnosed within 6 months following the last mammography, the last breast
density considered was the previous one, whenever it was not coincident with the baseline measure.
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Table 2. Posterior summaries of the parameters and hyperparameters of the breast cancer joint model.
Mean SD 2.5% Median 97.5% P (· > 0 | D)
β0 -1.4262 0.0346 -1.4964 -1.4251 -1.3608 0.0000
β1 -0.0524 0.0018 -0.0560 -0.0524 -0.0489 0.0000
σ0 2.6067 0.0227 2.5643 2.6059 2.6534
σ1 0.0053 0.0018 0.0015 0.0053 0.0087
γ1 -4.6994 0.0269 -4.7521 -4.6998 -4.6489
γ3 1.7362 0.0156 1.7060 1.7364 1.7675
λ 1.5366 0.1044 1.3287 1.5387 1.7386
η0 -7.6066 0.3369 -8.2476 -7.6011 -6.9337 0.0000
η1 0.6227 0.1716 0.2747 0.6308 0.9517 0.9984
η2 0.4535 0.1440 0.1644 0.4600 0.7210 1.0000
α 0.1490 0.0207 0.1089 0.1496 0.1887 1.0000
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Figure 1. Subject-specific profiles of BI-RADS measures for sixteen randomly selected women. The left panel corresponds to eight women
without breast cancer, and the right panel corresponds to eight women with breast cancer.
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Figure 2.Age-specific population distribution of breast density. Posterior mean and 95% credible interval of the probability associated to each
BI-RADS category with respect to age (top) and violin plot of the posterior marginal distribution of the latent breast density of an average
woman at ages 50, 55, 60, 65 and 70 (bottom). Horizontal dotted lines represent the posterior mean of the cut-points thus approximately
indicating the region of the latent density corresponding to ordinal BD categories a, b, c, and d (from bottom to top).
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Figure 3.Posterior distribution of the hazard ratios associated to family history of breast cancer and prior breast procedures.
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Figure 4.Approximate posterior mean and 95% credible interval with regard to age of the HRs of a BC diagnosis for women with breast density
b, c and d as compared with women with the same covariates and BD measurement a.
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Figure 5.Posterior mean and 95% credible band of the probability of a breast cancer-free diagnosis for women with IDs 942, 5 318, 9 672 and
17 540 without breast cancer at the end of the follow-up. The value of the probability at the lower right of each graphic is the subsequent
posterior mean at 70 years.
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Figure 6.Posterior predicted mean of the breast density in the BI-RADS scale over age for women with IDs with IDs 942, 5 318, 9 672 and
17 540 without breast cancer at the end of the follow-up.
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